These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis. Charni N, Juillet F, Garnero P. Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703 [Abstract] [Full Text] [Related]
10. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM. J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468 [Abstract] [Full Text] [Related]
11. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies. El-Masry S, El-Sayed IH, Lotfy M, Mahmoud L, El-Naggar M. J Immunoassay Immunochem; 2007 Mar; 28(2):91-105. PubMed ID: 17424828 [Abstract] [Full Text] [Related]
12. Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Ye B, Skates S, Mok SC, Horick NK, Rosenberg HF, Vitonis A, Edwards D, Sluss P, Han WK, Berkowitz RS, Cramer DW. Clin Cancer Res; 2006 Jan 15; 12(2):432-41. PubMed ID: 16428483 [Abstract] [Full Text] [Related]